GGrantIndex
Sort

15,440 grants matching organoids

Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy

$568,866
Allison M Bradbury · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · NS

Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.

$568,819
Maureen A McCall · University Of Louisville · R01 · FY2024 · EY

Defined microbial communities to prevent and eradicate infection by AMR pathogens

$568,690
Robert A Britton · Baylor College Of Medicine · U19 · FY2023 · AI

Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasions

$568,661
Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Pleiotropy in LMNA-associated Arrhythmogenic Cardiomyopathy

$568,552
Thomas V McDonald · University Of South Florida · R56 · FY2022 · HL

Improving intestinal symptoms in a Congenital Disorder of Glycosylation

$568,539
Jeffrey Sorelle · Ut Southwestern Medical Center · R01 · FY2025 · DK

A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer

$568,527
Jeff M Hasty · University Of California, San Diego · R01 · FY2022 · CA

A microbiome-informed platform for the development and testing of bacterial therapies for colorectal cancer

$568,526
Jeff M Hasty · University Of California, San Diego · R01 · FY2023 · CA

New Therapuetics for Pancreatic Cancer

$568,413
Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2024 · CA

Tumor selective inhibition of the WNT pathway

$568,218
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis

$568,115
Natalia B Ivanova · University Of Georgia · R01 · FY2025 · HL

Credentialing Models of Invasive Lobular Breast Cancer for Translational Research

$568,084
Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases

$568,004
Abraam M. Yakoub · University Of North Dakota · R01 · FY2022 · AG

Mechanobiology of Lung Fibrosis

$567,924
Daniel J. Tschumperlin · Mayo Clinic Rochester · R01 · FY2021 · HL

Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer

$567,785
Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2021 · CA

DECODING THE MECHANOREGULATION OF BREAST TUMOR ORGANOID INVASION, ONE CELL AT A TIME

$567,700
University Of California, San Diego · · FY2020 · Department of the Army

The role of RAMS11 in colorectal cancer progression and treatment resistance

$567,677
Christopher A Maher · Washington University · R01 · FY2023 · CA

Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer

$567,598
Adrian Vincent Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Functional analysis of autism risk genes during neural development using single cell seq

$567,505
Antonio Giraldez · Yale University · R01 · FY2022 · MH

Functional analysis of autism risk genes during neural development using single cell seq

$567,505
Antonio Giraldez · Yale University · R01 · FY2023 · MH

Tympanic membrane progenitor cells in homeostasis in injury

$567,222
Aaron Tward · University Of California, San Francisco · R01 · FY2022 · DC

Impact of AIM2 on Intestinal Stem Cell Differentiation During Inflammation

$567,205
Justin Ethan Wilson · University Of Arizona · R01 · FY2025 · DK

Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer

$567,204
Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA

Role of Sensory Innervation in High Fat Diet-Induced Hepatotoxicity

$567,143
Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2022 · DK

Metabolomics of cGVHD

$567,033
Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2025 · HL